These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14702246)

  • 1. Huntington's disease: phenomenological diversity of a neuropsychiatric condition that challenges traditional concepts in neurology and psychiatry.
    Tost H; Wendt CS; Schmitt A; Heinz A; Braus DF
    Am J Psychiatry; 2004 Jan; 161(1):28-34. PubMed ID: 14702246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Delayed diagnosis of Huntington's disease in a psychiatric setting].
    Tak LM; Sizoo B; de Stegge BMA; Adema S; van Duijn E; Kremer B
    Tijdschr Psychiatr; 2017; 59(6):372-375. PubMed ID: 28613370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
    Fragassi NA; Stanzione M; Angelini R; Di Maio L
    Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric aspects of Huntington's disease.
    Paulsen JS; Ready RE; Hamilton JM; Mega MS; Cummings JL
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):310-4. PubMed ID: 11511702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When is it not Huntington's disease?
    Heckmann JM; Bryer A; Greenberg LJ
    S Afr Med J; 2001 Feb; 91(2):132-3. PubMed ID: 11288392
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional brain changes in presymptomatic Huntington's disease.
    Reading SA; Dziorny AC; Peroutka LA; Schreiber M; Gourley LM; Yallapragada V; Rosenblatt A; Margolis RL; Pekar JJ; Pearlson GD; Aylward E; Brandt J; Bassett SS; Ross CA
    Ann Neurol; 2004 Jun; 55(6):879-83. PubMed ID: 15174024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychological evaluation can contribute to the diagnosis of movement disorders].
    Dubois B; Beato R; Villalpando JM
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S50-6. PubMed ID: 12773888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
    de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM
    Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural bases of dysphoria in early Huntington's disease.
    Paradiso S; Turner BM; Paulsen JS; Jorge R; Ponto LL; Robinson RG
    Psychiatry Res; 2008 Jan; 162(1):73-87. PubMed ID: 18068955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease: looking beyond the movement disorder.
    Morreale MK
    Adv Psychosom Med; 2015; 34():135-42. PubMed ID: 25832519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Theory of mind" is impaired in Huntington's disease.
    Brüne M; Blank K; Witthaus H; Saft C
    Mov Disord; 2011 Mar; 26(4):671-8. PubMed ID: 21384426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of depression on working memory in presymptomatic Huntington's disease.
    Nehl C; Ready RE; Hamilton J; Paulsen JS
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):342-6. PubMed ID: 11514640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and paraclinical diagnosis in psychiatry].
    Lebert F
    Encephale; 1999 Nov; 25 Spec No 5():19-21; discussion 22. PubMed ID: 10609098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peek inside the Huntington's brain: will functional imaging take us one step closer in solving the puzzle?
    Georgiou-Karistianis N
    Exp Neurol; 2009 Nov; 220(1):5-8. PubMed ID: 19679124
    [No Abstract]   [Full Text] [Related]  

  • 15. Unified Huntington's disease rating scale: clinical practice and a critical approach.
    Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
    Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conference at the Salpêtrière, 4 May 1983. Sudden behavior disorders with agitation in a 68-year-old man].
    Awada A; Poncet M; Signoret JL
    Rev Neurol (Paris); 1984; 140(6-7):446-51. PubMed ID: 6463498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Huntington disease: clinical and genetic study in a Spanish population].
    Solís Pérez MP; Palau Martínez F; Burguera Hernández JA; Salazar Cifré A
    Neurologia; 1995 Nov; 10(9):362-6. PubMed ID: 8554791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric aspects of depression.
    Salloway S; Duffy J
    R I Med; 1993 Aug; 76(8):425-30. PubMed ID: 8219386
    [No Abstract]   [Full Text] [Related]  

  • 19. 123I-ioflupane SPECT in Fahr disease.
    Paghera B; Caobelli F; Giubbini R
    J Neuroimaging; 2013 Jan; 23(1):157-8. PubMed ID: 21410813
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical periods of suicide risk in Huntington's disease.
    Paulsen JS; Hoth KF; Nehl C; Stierman L
    Am J Psychiatry; 2005 Apr; 162(4):725-31. PubMed ID: 15800145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.